Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:01 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 7,503,976 9.99% | -188,014 (-2.44%) | View |
| 2024-02-14 4:27 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | PERCEPTIVE ADVISORS LLC | 3,866,214 4.8% | -596,452 (-13.37%) | View |
| 2024-02-09 10:05 am Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | FMR LLC | 39,219,016 6.167% | 39,219,016 (New Position) | View |
| 2024-02-08 10:03 am Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | WELLINGTON MANAGEMENT GROUP LLP | 30,271,952 4.73% | -8,383,952 (-21.69%) | View |
| 2023-05-16 4:25 pm Sale | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | ORBIMED ADVISORS LLC | 3,777,778 4.8% | -482,913 (-11.33%) | View |
| 2023-04-25 4:16 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Access Industries Holdings LLC | 0 0% | -32,946,296 (Position Closed) | View |
| 2023-04-20 5:01 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | PERCEPTIVE ADVISORS LLC | 4,462,666 5.6% | 4,462,666 (New Position) | View |
| 2023-02-14 4:45 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 7,691,990 9.99% | -41,086,182 (-84.23%) | View |
| 2023-02-13 5:47 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | VIVO VENTURES VII LLC | 23,142,200 3.8% | 23,142,200 (New Position) | View |
| 2023-02-09 3:57 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Access Industries Holdings LLC | 32,946,296 5.45% | -18,165,352 (-35.54%) | View |
| 2023-02-06 2:36 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | WELLINGTON MANAGEMENT GROUP LLP | 26,770,960 4.43% | 26,770,960 (New Position) | View |
| 2022-12-27 4:25 pm Sale | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | ORBIMED ADVISORS LLC | 4,260,691 5.6% | -767,483 (-15.26%) | View |
| 2022-09-07 5:28 pm Purchase | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Growth Equity Opportunities Fund IV LLC | 46,447,651 7.9% | 3,809,520 (+8.93%) | View |
| 2022-08-12 2:29 pm Sale | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | ORBIMED ADVISORS LLC | 5,028,174 6.9% | -6,842,938 (-57.64%) | View |
| 2022-08-11 4:54 pm Purchase | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Abingworth LLP | 21,313,822 4.4% | 249,600 (+1.18%) | View |
| 2022-08-10 4:57 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Access Industries Holdings LLC | 51,111,648 10.48% | 6,667,200 (+15.00%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 48,778,172 9.99% | 7,235,168 (+17.42%) | View |
| 2022-02-11 5:20 pm Unchanged | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | Vivo Ventures VI LLC | 23,493,716 4.9% | 0 (Unchanged) | View |
| 2022-02-04 09:06 am Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | WELLINGTON MANAGEMENT GROUP LLP | 38,655,904 8.34% | 38,655,904 (New Position) | View |
| 2021-02-16 4:34 pm Purchase | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 41,543,004 9.99% | 41,543,004 (New Position) | View |